Statements (12)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:clinicalTrialPhase |
Phase 2
|
| gptkbp:developedBy |
Bionomics Limited
|
| https://www.w3.org/2000/01/rdf-schema#label |
Bionomics POI
|
| gptkbp:intendedUse |
treatment of anxiety disorders
|
| gptkbp:mechanismOfAction |
positive allosteric modulator of the alpha-7 nicotinic acetylcholine receptor
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:status |
investigational
|
| gptkbp:target |
gptkb:Generalized_Anxiety_Disorder
gptkb:Post-Traumatic_Stress_Disorder |
| gptkbp:bfsParent |
gptkb:Broken_Moon
|
| gptkbp:bfsLayer |
6
|